Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Current Leases: 2021-2024

Historic Current Leases for Janux Therapeutics (JANX) over the last 4 years, with Dec 2024 value amounting to $1.7 million.

  • Janux Therapeutics' Current Leases rose 34.99% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 34.99%. This contributed to the annual value of $1.7 million for FY2024, which is 15.29% up from last year.
  • As of FY2024, Janux Therapeutics' Current Leases stood at $1.7 million, which was up 15.29% from $1.5 million recorded in FY2023.
  • In the past 5 years, Janux Therapeutics' Current Leases registered a high of $1.7 million during FY2024, and its lowest value of $194,000 during FY2021.
  • Over the past 3 years, Janux Therapeutics' median Current Leases value was $1.5 million (recorded in 2023), while the average stood at $1.3 million.
  • Data for Janux Therapeutics' Current Leases shows a peak YoY skyrocketed of 293.30% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Janux Therapeutics' Current Leases stood at $194,000 in 2021, then soared by 293.30% to $763,000 in 2022, then spiked by 98.82% to $1.5 million in 2023, then climbed by 15.29% to $1.7 million in 2024.